|
🐜
|
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
12 auth.
W. O’Neill,
P. Serruys,
M. Knudtson,
G. van Es,
G. Timmis,
Coen van der Zwaan,
...
J. Kleiman,
J. Gong,
E. Roecker,
R. Dreiling,
J. Alexander,
R. Anders
|
7 |
2000 |
7
🐜
|
